PCSK9 inhibitors from bench to real world: a journey to improve CV outcomes in very high-risk patients. - Sponsored by Amgen (Europe) GmbH.
1 September 2020 (15:00 - 15:30)
Organised by:
4 More presentations in this session
Professor C. Ballantyne (Houston, US)
Professor G. De Ferrari (Turin, IT)
Professor K. Ray (London, GB)
Professor S. Goodman (Toronto, CA)
Access the full session
The Event
ESC Congress 2020
1 September 2020
15:00 CET
